The Triple Negative BC (TNBC) subtype includes BC tumours that have a negative expression status of the Oestrogen Receptor (ER), Progesterone Receptor (PR), and Human Epidermal Growth Factor 2 (HER2) (ER−, PR−, HER2−) [2,3]. This evidence concerns the gene ERBB2 and breast cancer.